Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 18 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Staging high-grade dysphasia and early cancer in Barrett's

Endoscopic mucosal resection provides pathologic staging information that is helpful after endoscopic ultrasound if a stage-determined approach is used in the management of high-grade dysplasia and of focal nodules in Barrett's esophagus, finds July's issue of Gastrointestinal Endoscopy.

News image

fiogf49gjkf04

Accurate staging of high-grade dysplasia and of early cancer in Barrett's esophagus is important in the selection of patients for endoscopic therapy.

Dr Charles Lightdale and colleagues from New York staged patients with Barrett's esophagus and biopsy specimen proven high-grade dysphasia using endoscopic ultrasonography.

Patients with adenocarcinoma in focal nodular lesions or in endoscopically unapparent flat lesions in short-segment Barrett's esophagus were also initially staged with endoscopes ultrasonography.

The team performed cap-assisted endoscopic mucosal resection in patients with disease limited to the mucosa on endoscopic ultrasound.

The depth of tumor invasion on endoscopic mucosal resection specimens was classified in a similar manner to squamous-cell cancer of the esophagus.

The researcher‘s classification of the depth of tumor invasion included m1 as epithelial layer or dysplasia, m2 as lamina propria invasion, m3 as muscularis mucosae invasion, and sm as submucosal invasion.

The team performed endoscopic ultrasound in 48 consecutive patients, of which 27 had focal nodular lesions and 21 had microscopic lesions.

Endoscopic mucosal resection confirmed epithelial layer or dysplasia disease in 19 of 25 patients
Gastrointestinal Endoscopy

The research team diagnosed submucosal invasion in 8 patients and endoscopic mucosal resection was carried out in the remaining 40 patients without significant complications.

In the 25 patients with high-grade dysplasia on prior biopsy specimens, endoscopic mucosal resection confirmed m1 disease in 19, whereas in 6, invasive adenocarcinoma was detected.

The research team found that in the 15 patients with invasive cancer on prior biopsy specimens and staging with endoscopic ultrasound, intramucosal carcinoma was confirmed in 9.

However, in 6 of these patients, submucosal invasion was found.

Overall, the team noted that endoscopic ultrasound provided accurate staging in 41 of the 48 patient with 1 patient overstaged and 6 patients understaged.

The researchers compared these results with pathologic staging obtained by surgery or endoscopic mucosal resection.

Of the 34 patients with m1 to m3 staging after endoscopic mucosal resection, 29 were treated endoscopically and had no evidence of cancer after a mean follow-up of 23 months.

Dr Lightdale's team concludes, “Endoscopic mucosal resection provides pathologic staging information”

“In addition, it may be helpful after endoscopic ultrasound if a stage-determined approach is used in the management of high-grade dysplasia and of early cancer in Barrett's esophagus.”

“Endoscopic mucosal resection may be particularly useful for staging of focal nodules or in short-segment Barrett's esophagus with microscopic lesions when endoscopic therapy is an option.”

Gastrointest endosc 2005:62(1): 16
15 July 2005

Go to top of page Email this page Email this page to a colleague

 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Medication nonadherence and health care costs
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Socioeconomic characteristics in diverticular disease
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Barriers to hepatitis C treatment
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 31 October 2017 
Endoscopic indices of disease activity for Crohn’s
 31 October 2017 
Follow-up of positive results on fecal blood tests
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Fecal microbiota transplantation
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy
 24 October 2017 
Eosinophilic esophagitis with swallowed topical corticosteroids
 24 October 2017 
Meta-analysis in nutritiona research
 23 October 2017 
NAFLD-related hepatocellular carcinoma in liver resection
 23 October 2017 
Outcome of hepatic sarcoidosis
 20 October 2017 
Hospital readmissions reduction program
 20 October 2017 
Conversion of planned colonoscopy to sigmoidoscopy
 19 October 2017 
Fecal immunochemical tests in colorectal cancer screening
 19 October 2017 
Current management of chylous ascites

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us